It is exactly considerations like this
that make the DNDN disregard for
science more puzzling. Their IT infrastructure,
in vitro approach, and need to monitor contamination,
LPS is a good case in point, give them
the ideal platform from which to sort out these
inconsistent results. So, why the interest in
video and politics? A few IT guys playing with
their clinical monitoring data could probably
do quite a bit. Again, there is some hope their
new CFO is leading an array based science effort
but I won't make any assumptions until I
see some evidence ...
News 
Market Data 
Discover 
